Antiphospholipid antibodies, ischemic stroke in young adults, and calcium supplementation: a hypothesis

J Newmark1, H L Newmark, L A Marden

  • 1Neurology Service, Madigan Army Medical Center, Tacoma, WA, USA.

Military Medicine
|June 28, 2000
PubMed

Insights

This study suggests adding calcium and vitamin D supplements to anticoagulant therapy for younger ischemic stroke patients with antiphospholipid antibodies. This combined approach may offer additive benefits for stroke prevention.

Area of Science:

  • Neurology
  • Hematology
  • Nutritional Science

Background:

  • Ischemic stroke in young adults lacking traditional risk factors presents a treatment challenge.
  • Antiphospholipid antibodies are a key risk factor in these patients.
  • Current standard treatment involves anticoagulant therapy, but optimal adjunctive strategies are debated.

Observation:

  • The optimal treatment strategy for ischemic stroke in young patients with antiphospholipid antibodies remains unclear.
  • Dietary supplementation with calcium and vitamin D is proposed as an adjunct therapy.

Findings:

  • The study hypothesizes that calcium and vitamin D supplementation will provide additive benefits to standard anticoagulant therapy.
  • This hypothesis requires validation through large-scale clinical trials.

Implications:

  • Investigating combined therapy could lead to improved stroke management protocols for affected patients.
  • The military health care system's infrastructure is suitable for conducting such extensive research.
  • Establishing the efficacy of this combined approach may enhance patient recovery and reduce stroke recurrence.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...